Avidity Biosciences
RNA
#3317
Rank
$3.34 B
Marketcap
$27.84
Share price
4.13%
Change (1 day)
5.47%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of December 2024 : $1.50 Billion USD

According to Avidity Biosciences's latest financial reports the company has $1.50 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$1.50 B152.2%
2023-12-31$0.59 B-2.52%
2022-12-31$0.61 B50.59%
2021-12-31$0.40 B23.59%
2020-12-31$0.32 B246.95%
2019-12-31$94.57 M2960.78%
2018-12-31$3.09 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$1.13 B-24.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.36 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.35 B-9.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.51 B-65.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.27 B-81.41%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$20.47 B 1,263.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.66 B 210.40%๐Ÿ‡ฌ๐Ÿ‡ง UK